<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//sundancebio.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://sundancebio.com/sundance-biosciences-announces-presentation-of-phase-1-results-for-sun-627-a-brain-penetrant-tyk2-inhibitor-for-the-treatment-of-multiple-sclerosis-ms/</loc>
		<lastmod>2026-10-21T17:23:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://sundancebio.com/sundance-biosciences-announces-first-patient-dosed-in-u-s-phase-2-clinical-trial-of-sun-627-for-progressive-forms-of-multiple-sclerosis-ms/</loc>
		<lastmod>2026-10-22T11:05:08+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->